Buy Genpact on ATS-Led Growth and Margin Leverage: Tactical Long with Defined Stop
Genpact looks attractively positioned: accelerating demand for advanced technology services (ATS), improving margins and healthy free cash flow support upside from a $39 handle. Valuation is reasonable (P/E ~12, EV/EBITDA ~8.4), balance sheet is solid and the company pays a modest dividend - we lay out an actionable long trade with entry, stop and …